OBJECTIVE: A substantial proportion of patients develop posttraumatic stress disorder (PTSD) following myocardial infarction (MI). Previous research on the trajectory over time of PTSD in post-MI patients is scant and refers to self-rated posttraumatic symptoms. The aim of this study was to investigate the longitudinal course of an interviewer-rated diagnosis of PTSD and PTSD symptom severity following MI. METHODS: Study participants were 40 patients (78% men, mean age 54 +/- 8 years) who were diagnosed with PTSD using the Clinician-administered PTSD Scale (CAPS) after an average of 5 +/- 4 months (range 2-16 months) following an index MI. After a mean follow-up of 26 +/- 6 months (range 12-36 months), 24 patients underwent a second diagnostic interview. RESULTS: Two-thirds of patients (n = 16) still qualified for a diagnosis of PTSD at follow-up. In all 24 patients, total PTSD symptoms (p = 0.001), re-experiencing symptoms (p < 0.001), avoidance symptoms (p = 0.015), and, with borderline significance, hyperarousal symptoms (p < 0.06) had all decreased over time. However, in the subgroup of the 16 patients who had retained PTSD diagnostic status at follow-up, symptoms of avoidance (p = 0.23) and of hyperarousal (p = 0.48) showed no longitudinal decline. Longer duration of follow-up was associated with a greater decrease in avoidance symptoms (p = 0.029) and, with borderline significance, in re-experiencing symptoms (p < 0.07) across all patients. CONCLUSION: Although PTSD symptomatology waned over time and in relation to longer follow-up, two-thirds of patients still qualified for a diagnosis of PTSD 2 years after the initial diagnosis. In post-MI patients, clinical PTSD is a considerably persistent condition.
OBJECTIVE: A substantial proportion of patients develop posttraumatic stress disorder (PTSD) following myocardial infarction (MI). Previous research on the trajectory over time of PTSD in post-MI patients is scant and refers to self-rated posttraumatic symptoms. The aim of this study was to investigate the longitudinal course of an interviewer-rated diagnosis of PTSD and PTSD symptom severity following MI. METHODS: Study participants were 40 patients (78% men, mean age 54 +/- 8 years) who were diagnosed with PTSD using the Clinician-administered PTSD Scale (CAPS) after an average of 5 +/- 4 months (range 2-16 months) following an index MI. After a mean follow-up of 26 +/- 6 months (range 12-36 months), 24 patients underwent a second diagnostic interview. RESULTS: Two-thirds of patients (n = 16) still qualified for a diagnosis of PTSD at follow-up. In all 24 patients, total PTSD symptoms (p = 0.001), re-experiencing symptoms (p < 0.001), avoidance symptoms (p = 0.015), and, with borderline significance, hyperarousal symptoms (p < 0.06) had all decreased over time. However, in the subgroup of the 16 patients who had retained PTSD diagnostic status at follow-up, symptoms of avoidance (p = 0.23) and of hyperarousal (p = 0.48) showed no longitudinal decline. Longer duration of follow-up was associated with a greater decrease in avoidance symptoms (p = 0.029) and, with borderline significance, in re-experiencing symptoms (p < 0.07) across all patients. CONCLUSION: Although PTSD symptomatology waned over time and in relation to longer follow-up, two-thirds of patients still qualified for a diagnosis of PTSD 2 years after the initial diagnosis. In post-MI patients, clinical PTSD is a considerably persistent condition.
Authors: Anna Wikman; Nadine Messerli-Bürgy; Gerard J Molloy; Gemma Randall; Linda Perkins-Porras; Andrew Steptoe Journal: J Behav Med Date: 2011-07-09
Authors: Mary Princip; Aju P Pazhenkottil; Jürgen Barth; Ulrich Schnyder; Hansjörg Znoj; Jean-Paul Schmid; Rebecca E Langraf-Meister; Roland von Känel; Katharina Ledermann Journal: Front Psychiatry Date: 2022-05-30 Impact factor: 5.435
Authors: Roland von Känel; Chiara C Abbas; Stefan Begré; Marie-Louise Gander; Hugo Saner; Jean-Paul Schmid Journal: Dig Dis Sci Date: 2009-12-24 Impact factor: 3.199
Authors: Roland von Känel; Rebecca E Meister-Langraf; Jürgen Barth; Ulrich Schnyder; Aju P Pazhenkottil; Katharina Ledermann; Jean-Paul Schmid; Hansjörg Znoj; Claudia Herbert; Mary Princip Journal: Front Psychiatry Date: 2021-05-14 Impact factor: 4.157
Authors: Mary Princip; Miriam Koemeda; Rebecca E Meister; Jürgen Barth; Ulrich Schnyder; Hansjörg Znoj; Jean-Paul Schmid; Roland von Känel Journal: Health Psychol Open Date: 2015-06-29
Authors: Aurora Dollenberg; Sebastian Moeller; Caroline Lücke; Ruihao Wang; Alexandra P Lam; Alexandra Philipsen; Jürgen M Gschossmann; Falk Hoffmann; Helge H O Müller Journal: BMC Psychiatry Date: 2021-06-07 Impact factor: 3.630
Authors: Jeffrey Birk; Ian Kronish; Bernard Chang; Talea Cornelius; Marwah Abdalla; Joseph Schwartz; Joan Duer-Hefele; Alexandra Sullivan; Donald Edmondson Journal: Health Psychol Bull Date: 2019-01-14